{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:00:15Z","timestamp":1787169615159,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Gonadotropin releasing hormone analogues (GnRHa) are commonly used to treat central precocious puberty (CPP). Generally, they are well-tolerated; however adverse reactions have been reported. Local adverse events occur in 10-15% of the patients who were treated with GnRHa. Anaphylactoid reactions with GnRHa are very rarely seen. The aim of this study is to report our clinical experience with hypersensitivity reactions seen in pediatric patients receiving leuprolide acetate (LA) and triptorelin acetate (TA) in CPP at the single pediatric tertiary medical center and to evaluate the incidence rate of hypersensitivity reactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective study included children with CPP who were treated with GnRHa (LA and TA) at our hospital between January 2013 and December 2020. We analyzed clinical characteristics of patients who experienced adverse reactions and analyzed the incidence rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Seven side effects (adverse reactions) (0.69%) were observed among total of 1010 CPP patients who were treated with TA and LA. Sterile abscesses were observed in 3 patients (0.29%). None of the patients had an anaphylaxis. Tremors of both hands, a vomiting episode, an urticarial rash, and musculoskeletal stiffness were observed in one patient each.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In our study, mild reactions were seen in 7 patients. GnRHa can be safely used and well-tolerated medications; but exceedingly rare, severe reactions can be developed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijem.ijem_333_21","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T06:47:39Z","timestamp":1644994059000},"page":"527-531","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of Hypersensitivity Reactions with Leuprolide Acetate and Triptorelin Acetate in Children"],"prefix":"10.4103","volume":"25","author":[{"given":"Azize P\u0131nar","family":"Metbulut","sequence":"first","affiliation":[{"name":"Division of Pediatric Allergy and Immnunology, University Health of Science, Ankara City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keziban Toksoy","family":"Ad\u0131g\u00fczel","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, University Health of Science, Ankara City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candan","family":"\u0130slamo\u011flu","sequence":"additional","affiliation":[{"name":"Division of Pediatric Allergy and Immnunology, University Health of Science, Ankara City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Boyraz","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, University Health of Science, Ankara City Hospital, Ankara, Turkey"},{"name":"Department of Pediatric Endocrinology, Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine Dibek","family":"M\u0131s\u0131rl\u0131o\u011flu","sequence":"additional","affiliation":[{"name":"Division of Pediatric Allergy and Immnunology, University Health of Science, Ankara City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"B1-20240828","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1517\/13543784.16.11.1851","article-title":"Leuprolide acetate: A drug of diverse clinical applications","volume":"16","author":"Wilson","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"B2-20240828","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1442-2042.2011.02886.x","article-title":"Life-threatening anaphylaxis to leuprorelin acetate depot: Case report and review of the literature","volume":"19","author":"Fujisaki","year":"2012","journal-title":"Int J Urol"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/15569527.2010.487505","article-title":"Hypersensitivity vasculitis associated with leuprolide (Lupron)","volume":"29","author":"Gnanaraj","year":"2010","journal-title":"Cutan Ocul Toxicol"},{"key":"B4-20240828","doi-asserted-by":"crossref","first-page":"135","DOI":"10.6065\/apem.2014.19.3.135","article-title":"Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty","volume":"19","author":"Lee","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40521-019-0200-1","article-title":"Phenotypes and natural evolution of drug hypersensitivity","volume":"6","author":"Dona","year":"2019","journal-title":"Curr Treat Options Allergy"},{"key":"B6-20240828","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/247386","article-title":"Evaluating the efficacy of treatment with a GnRH analogue in patients with central precocious puberty","author":"Kendirci","year":"2015","journal-title":"Int J Endocrinol 2015"},{"key":"B7-20240828","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/1744666X.2018.1410059","article-title":"Diagnosing and managing patients with drug hypersensitivity","volume":"14","author":"Fernandez","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000505329","article-title":"Management of systemic hypersensitivity reactions to gonadotropin-releasing hormone analogues during treatment of central precocious puberty","volume":"93","author":"Kirkgoz","year":"2020","journal-title":"Horm Res Paediatr"},{"key":"B9-20240828","first-page":"923","article-title":"A patient developing anaphylaxis and sensitivity to two different GnRH analogues and a review of literature","volume":"28","author":"\u00d6kdemir","year":"2015","journal-title":"J Pediatr Endocr Met"},{"key":"B10-20240828","first-page":"943","article-title":"Recurrent anaphylaxis to a depot form of GnRH analogue","volume":"78","author":"Letterie","year":"1991","journal-title":"Obstet Gynecol"},{"key":"B11-20240828","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5694\/j.1326-5377.1994.tb127543.x","article-title":"Anaphylactic reaction to LHRH analogue, leuprorelin","volume":"161","author":"Taylor","year":"1994","journal-title":"Med J Aust"},{"key":"B12-20240828","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3816\/CGC.2007.n.005","article-title":"Anaphylaxis to leuprolide acetate depot injection during treatment for prostate cancer","volume":"5","author":"Grant","year":"2007","journal-title":"Clin Genitourin Cancer"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1592\/phco.26.12.1811","article-title":"Recurrent anaphylaxis associated with gonadotropin-releasing hormone analogs: Case report and review of the literature","volume":"26","author":"Lam","year":"2006","journal-title":"Pharmacotherapy"},{"key":"B14-20240828","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/all.12886","article-title":"In vitro tests for drug hypersensitivity reactions: An ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"71","author":"Mayorga","year":"2016","journal-title":"Allergy"},{"key":"B15-20240828","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brockow","year":"2002","journal-title":"Allergy"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs\u2014An ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"B17-20240828","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: General considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"B18-20240828","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12879-020-05756-3","article-title":"A case of recurrent sterile abcesses following tetanus-diphteria vaccination treated with corticosteroids","volume":"21","author":"Kaya","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B19-20240828","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/eje.1.02056","article-title":"Triptorelin 3-month CPP study group. Three-month sustained-release triptorelin (11.25mg) in the treatment of central precocious puberty","volume":"154","author":"Carel","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"B20-20240828","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0015-0282(00)00598-7","article-title":"A crossover study of triptorelin and leuprolin acetate","volume":"74","author":"Cheung","year":"2000","journal-title":"Fertil Steril"},{"key":"B21-20240828","doi-asserted-by":"crossref","first-page":"E136","DOI":"10.1111\/j.1440-1754.2011.02083.x","article-title":"Sterile abscess formation associated with depot leuprolide acetate theraphy for central precocious puberty","volume":"48","author":"Johnson","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"B22-20240828","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1365-2133.2005.06341.x","article-title":"Leuprorelin acetate granulomas: Case reports and review of the literature","volume":"152","author":"Yasukawa","year":"2005","journal-title":"Br J Dermatol"},{"key":"B23-20240828","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MAJ.0b013e31820094da","article-title":"Anaphylactic reaction to different gonadotropin-releasing hormone agonists for the treatment of endometriosis","volume":"341","author":"L\u00fcchinger","year":"2011","journal-title":"Am J Med Sci"},{"key":"B24-20240828","first-page":"780","article-title":"Fixed drug eruption induced by leuprorelin","volume":"142","author":"Salins","year":"2015","journal-title":"Ann Dermatol Venereol"},{"key":"B25-20240828","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1080\/00016340600608717","article-title":"Leuprolide acetate-induced leukocytoclastic vasculitis","volume":"86","author":"Turk","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B26-20240828","first-page":"755","article-title":"Leuprolide acetate-induced generalized papular eruption","volume":"13","author":"Burris","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"B27-20240828","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","article-title":"ESPE-LWPES GnRH analogs consensus conference group, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"key":"B29-20240828","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/pai.12927","article-title":"Successful desensitization to gonadotropin-releasing hormone analogue triptorelin acetate using a sustained-release depot preparation","volume":"29","author":"Chan Ng","year":"2018","journal-title":"Pediatr Allergy Immunol"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_333_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:10:00Z","timestamp":1787166600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_333_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijem.ijem_333_21","relation":{},"ISSN":["2230-9500","2230-8210"],"issn-type":[{"value":"2230-9500","type":"print"},{"value":"2230-8210","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"2021-07-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}